Study identifier:SD-039-0691
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A comparison of the effectiveness of treatment with Symbicort Turbuhaler (budesonide/formoterol; 160/4.5 mcg) Single Inhaler Therapy and Seretide Diskus (salmeterol/fluticasone; 50/100, 50/250 or 50/500 mcg) plus Ventoline (salbutamole) as needed in steroid-treated adult and adolescent asthmatic subjects. A randomised, open, parallel-group, phase IIIB, multicentre, 12-month study.
asthma
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|